Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Acta Neurochir (Wien) ; 99(3-4): 157-60, 1989.
Artículo en Inglés | MEDLINE | ID: mdl-2549767

RESUMEN

We report the case of a 26-year-old man in whom glioblastoma multiforme had recurred six months following a subtotal resection. Despite radiotherapy and a course of interferon beta and ACNU, the tumour increased in size (to 3 cm) and there was neurological deterioration. Treatment was then initiated with LAK cells, together with ACNU and interferon beta. After three courses of LAK cells, tumour size was markedly reduced, and at about six months the tumour had nearly disappeared on computed tomographic (CT) scans. At one year, and after nine courses of LAK cell therapy (total dose of 2.7 x 10(9) cells) infused via an Ommaya reservoir and supplemented by ACNU and interferon beta, the tumour has disappeared and the patient is considered to be in complete remission since 6 months. This marked response is thought to be due chiefly to LAK cell therapy. The relatively low dose administered was well-tolerated.


Asunto(s)
Neoplasias Encefálicas/terapia , Glioblastoma/terapia , Inmunización Pasiva/métodos , Recurrencia Local de Neoplasia/terapia , Adulto , Neoplasias Encefálicas/cirugía , Terapia Combinada , Lóbulo Frontal/cirugía , Glioblastoma/cirugía , Humanos , Interferón Tipo I/administración & dosificación , Interleucina-2/administración & dosificación , Células Asesinas Naturales/trasplante , Masculino , Nimustina/administración & dosificación , Lóbulo Parietal/cirugía , Complicaciones Posoperatorias/terapia , Proteínas Recombinantes/administración & dosificación
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...